Results 361-380 of 800 for hpv

Written Answers — Department of Health: Cancer Screening Programmes (5 Feb 2019)

Simon Harris: I take it that the Deputy is referring to the cost of a smear retest following the issue that has arisen in relation to secondary HPV testing. Where low grade changes are detected on a cervical smear test, a second, so-called ‘triage test’ – which looks for the HPV virus – is carried out by laboratories. If HPV is found, women are recommended to attend for...

Written Answers — Department of Health: Cancer Screening Programmes (5 Feb 2019)

Simon Harris: ...and governance, laboratory services and procurement, open disclosure, cancer registration, other screening programmes and resolution. As the Deputy will be aware, I have also asked the HSE to introduce HPV testing as the primary screening method for the prevention of cervical cancer. The HPV test is a more accurate testing mechanism than liquid-based cytology, which is the current...

Written Answers — Department of Health: Cancer Screening Programmes (5 Feb 2019)

Simon Harris: Where low grade changes are detected on a cervical smear test, a second, so-called ‘triage test’ – which looks for the HPV virus – is carried out by laboratories. If HPV is found, women are recommended to attend for further testing. If HPV is not found, women are recommended to attend for routine screening again in 3-5 years. In the test used by the laboratory...

Written Answers — Department of Health: Cancer Screening Programmes (31 Jan 2019)

Simon Harris: ...capacity internationally, which would improve the turnaround time of results. However, I am advised that cytology capacity is a challenge internationally, as countries start to move to primary HPV screening. As referenced by the Deputy, the HSE is developing a capacity plan which takes account of available capacity and expected demand, with the aim of bringing the programme into...

Written Answers — Department of Health: Cancer Screening Programmes (30 Jan 2019) See 1 other result from this answer

Clare Daly: 207. To ask the Minister for Health if the roll-out of the new and more accurate HPV screening test for cervical cancer has been impacted or delayed by the controversy over the disclosure of cervical screening audit results in May 2018. [4638/19]

Written Answers — Department of Health: Cancer Screening Programmes (29 Jan 2019)

Simon Harris: ...to source additional screening capacity, which would improve the turnaround time of results. However, sourcing capacity and resources is a global challenge as countries start to move to primary HPV screening, which vastly reduces the requirement for cytology screening staff. The HSE is currently developing a capacity plan to take account of available capacity and expected demand, with...

Written Answers — Department of Health: Vaccination Programme (29 Jan 2019) See 1 other result from this answer

Clare Daly: 310. To ask the Minister for Health the reason HIQA in its HTA report on extending the HPV vaccine to boys published in December 2018 used a Norwegian definition of a serious adverse reaction instead of the EU/EMA/HPRA definition of a serious adverse reaction as set out in guidelines (details supplied). [3765/19]

Written Answers — Department of Health: Cancer Screening Programmes (29 Jan 2019)

Simon Harris: ...HSE advises that there are procedures in place to deal with this issue as and when it arises. Where low grade changes are detected on a cervical smear test, a second test which looks for the HPV virus is then carried out. The Deputy will be aware that a separate issue has arisen in relation to this secondary HPV test. The HSE has advised that some HPV tests carried out by Quest...

Ceisteanna ar Reachtaíocht a Gealladh - Questions on Promised Legislation (24 Jan 2019)

Simon Coveney: I have heard some doctors speak about this issue in the media today. It is important to say the problems related to secondary HPV testing are not solely connected to the increased volume of smear tests. We need to be accurate in considering what has contributed to what problem. There are two separate issues. One is capacity and one is secondary screening, when it has been necessary, in...

Ceisteanna ó Cheannairí - Leaders' Questions (24 Jan 2019) See 4 other results from this debate

Simon Coveney: The test for HPV should be carried out within 30 days of the sample having been given by a woman. This is the secondary test when low-grade changes are detected. The HSE is working with Quest Diagnostics, which is one of the three laboratories used by the cervical cancer screening programme, to address the situation that has been identified regarding HPV tests. Of the approximately 500,000...

Seanad: An tOrd Gnó - Order of Business (24 Jan 2019)

Catherine Ardagh: ...lives but we need to be very proactive now. We need to consider the Scally report and ensure its recommendations are implemented. These cover open disclosure and quickly introducing the simpler HPV testing system. We need to encourage women to continue to get cervical screening tests and do so in a positive manner. We must be pragmatic and ensure sufficient resources are in place if we...

Written Answers — Department of Health: Pharmaceutical Sector (24 Jan 2019)

Simon Harris: ...in the number of referrals and regulatory actions arising from the outcome of these referrals. Public scrutiny and the role of the regulator in relation to medical devices and medicines such as the HPV vaccine has increased, while compliance activity is also increasing. Over the last several years, the HPRA has continued to enhance services to support the pharmaceutical industry in...

Written Answers — Department of Health: Vaccination Programme (24 Jan 2019) See 1 other result from this answer

Róisín Shortall: 207. To ask the Minister for Health the steps he will take to ensure that the HSE national immunisation office will update its delivery and communication strategies for the HPV vaccine programme in advance of the extension of the vaccine to boys in September 2019; and if he will make a statement on the matter. [3637/19]

Ceisteanna ó Cheannairí - Leaders' Questions (23 Jan 2019)

Leo Varadkar: ...is being implemented. We put in a package of supports for the women affected by the audit including medical cards, experimental medicines and other supports. We have taken the decision to extend the HPV vaccine to boys this year and to introduce a new, more modern smear test - one of the first countries to do so - which is more accurate. That will be done this year. Important progress...

Written Answers — Department of Health: Cancer Screening Programmes (22 Jan 2019)

Simon Harris: ..., the HSE is aiming to source additional screening capacity, which would improve the turnaround time of results. However, sourcing capacity and resources is a global challenge as countries start to move to primary HPV screening, which vastly reduces the requirement for cytology screening staff.  The HSE is currently developing a capacity plan to take account of available capacity...

Written Answers — Department of Health: Cancer Screening Programmes (22 Jan 2019)

Simon Harris: ...is aiming to source additional screening capacity, which would improve the turnaround time of results. However, sourcing capacity and resources is a global challenge as countries start to move to primary HPV screening, which vastly reduces the requirement for cytology screening staff. The HSE is currently developing a capacity plan to take account of available capacity and expected...

Written Answers — Department of Health: Vaccination Programme (22 Jan 2019) See 1 other result from this answer

Michael Healy-Rae: 471. To ask the Minister for Health if he will address matters (details supplied) in relation to the HPV vaccine; and if he will make a statement on the matter. [3107/19]

Written Answers — Department of Health: Cancer Screening Programmes (17 Jan 2019)

Simon Harris: ...to source additional screening capacity, which would improve the turnaround time of results. However, sourcing capacity and resources is a global challenge as countries start to move to primary HPV screening, which vastly reduces the requirement for cytology screening staff. The HSE is currently developing a capacity plan to take account of available capacity and expected demand, with...

Saincheisteanna Tráthúla - Topical Issue Debate: Cancer Screening Programmes (15 Jan 2019)

Finian McGrath: ...on CervicalCheck. Significant funding has been allocated in budget 2019 to support the implementation of the recommendations. In addition, funding will also support the extension in 2019 of the HPV vaccine to boys, as well as the introduction of HPV testing as the primary cervical screening test. The work of the expert panel review, together with the implementation of the recommended...

Ceisteanna - Questions: Cabinet Committee Meetings (15 Jan 2019)

Leo Varadkar: ...by the HSE within the available funding for the coming year. It outlines the provision of a range of Government initiatives including mental health enhancements, disability services, cervical screening, the HPV vaccine for boys, the introduction of termination of pregnancy services and the merger of the three children’s hospitals in Dublin into Children’s Health Ireland,...